Antiretroviral Pregnancy Registry Analysis of Outcomes of Maternal DTG Use in Pregnancy

September 29 - October 3, 2021; Virtual
Analysis of international registry data through January 2021 shows that prevalence of birth defects with prenatal DTG is comparable with that seen in the general population.
Format: Microsoft PowerPoint (.ppt)
File Size: 664 KB
Released: October 5, 2021

Acknowledgements

Provided by Clinical Care Options, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
ViiV Healthcare

Related Content

Commentary on lessons learned during the COVID-19 pandemic for reducing barriers to HIV prevention service access, from Clinical Care Options (CCO)

Latesha Elopre, MD, MSPH Michael A. Fordham, BA Released: December 7, 2021

From Clinical Care Options (CCO) and Dr. Jurgen K. Rockstroh and Dr. Giada Sebastiani: the risk factors of NAFLD or NASH in patients with HIV

Jürgen K. Rockstroh, MD Giada Sebastiani, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Released: December 7, 2021 Expired: December 6, 2022

Dr Milosz Parczewski and Clinical Care Options (CCO): Update from EACS 2021 on the HIV care continuum in Eastern Europe

Milosz Parczewski, MD, PhD Released: December 3, 2021

Commentary from Dr Yan Zhao on the latest findings from EACS 2021 highlighting the unique challenges of older people living with HIV, from Clinical Care Options (CCO)

person default Yan Zhao, MD Released: November 30, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue